These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29380527)

  • 1. The Sphingosine 1-Phosphate Analogue FTY720 Alleviates Seizure-induced Overexpression of P-Glycoprotein in Rat Hippocampus.
    Gao F; Gao Y; Meng F; Yang C; Fu J; Li Y
    Basic Clin Pharmacol Toxicol; 2018 Jul; 123(1):14-20. PubMed ID: 29380527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine 1-phosphate enhances the excitability of rat sensory neurons through activation of sphingosine 1-phosphate receptors 1 and/or 3.
    Li C; Li JN; Kays J; Guerrero M; Nicol GD
    J Neuroinflammation; 2015 Apr; 12():70. PubMed ID: 25880547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fingolimod (FTY720) inhibits neuroinflammation and attenuates spontaneous convulsions in lithium-pilocarpine induced status epilepticus in rat model.
    Gao F; Liu Y; Li X; Wang Y; Wei D; Jiang W
    Pharmacol Biochem Behav; 2012 Dec; 103(2):187-96. PubMed ID: 22960129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1.
    Janes K; Little JW; Li C; Bryant L; Chen C; Chen Z; Kamocki K; Doyle T; Snider A; Esposito E; Cuzzocrea S; Bieberich E; Obeid L; Petrache I; Nicol G; Neumann WL; Salvemini D
    J Biol Chem; 2014 Jul; 289(30):21082-97. PubMed ID: 24876379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of fingolimod, nitric oxide inhibitor, and P-glycoprotein inhibitor in modulating the P-glycoprotein expression via an endothelin-sphingolipid pathway in an animal model of pharmacoresistant epilepsy.
    Garg N; Joshi R; Bhatia A; Bansal S; Chakrabarti A; Prakash A; Saikia B; Modi M; Medhi B
    Indian J Pharmacol; 2023; 55(5):307-314. PubMed ID: 37929409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine 1-phosphate but not Fingolimod protects neurons against excitotoxic cell death by inducing neurotrophic gene expression in astrocytes.
    Tran C; Heng B; Teo JD; Humphrey SJ; Qi Y; Couttas TA; Stefen H; Brettle M; Fath T; Guillemin GJ; Don AS
    J Neurochem; 2020 Apr; 153(2):173-188. PubMed ID: 31742704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pluronic P85-coated poly(butylcyanoacrylate) nanoparticles overcome phenytoin resistance in P-glycoprotein overexpressing rats with lithium-pilocarpine-induced chronic temporal lobe epilepsy.
    Fang Z; Chen S; Qin J; Chen B; Ni G; Chen Z; Zhou J; Li Z; Ning Y; Wu C; Zhou L
    Biomaterials; 2016 Aug; 97():110-21. PubMed ID: 27162079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats.
    van Vliet EA; van Schaik R; Edelbroek PM; Redeker S; Aronica E; Wadman WJ; Marchi N; Vezzani A; Gorter JA
    Epilepsia; 2006 Apr; 47(4):672-80. PubMed ID: 16650133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fingolimod protects against cerebral ischemia reperfusion injury in rats by reducing inflammatory cytokines and inhibiting the activation of p38 MAPK and NF-κB signaling pathways.
    Zhang L; Sui R; Zhang L
    Neurosci Lett; 2022 Feb; 771():136413. PubMed ID: 34942319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosin-1-phosphate Receptor 1: a Potential Target to Inhibit Neuroinflammation and Restore the Sphingosin-1-phosphate Metabolism.
    Kolahdooz Z; Nasoohi S; Asle-Rousta M; Ahmadiani A; Dargahi L
    Can J Neurol Sci; 2015 May; 42(3):195-202. PubMed ID: 25860537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin effect is enhanced by sphingosine-1-phosphate signaling antagonist in breast cancer.
    Katsuta E; Yan L; Nagahashi M; Raza A; Sturgill JL; Lyon DE; Rashid OM; Hait NC; Takabe K
    J Surg Res; 2017 Nov; 219():202-213. PubMed ID: 29078883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain.
    Cannon RE; Peart JC; Hawkins BT; Campos CR; Miller DS
    Proc Natl Acad Sci U S A; 2012 Sep; 109(39):15930-5. PubMed ID: 22949658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociceptive effects of FTY720 during trauma-induced neuropathic pain are mediated by spinal S1P receptors.
    Zhang DD; Linke B; Suo J; Zivkovic A; Schreiber Y; Ferreirós N; Henke M; Geisslinger G; Stark H; Scholich K
    Biol Chem; 2015 Jun; 396(6-7):783-94. PubMed ID: 25720064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTY720 Attenuates Angiotensin II-Induced Podocyte Damage via Inhibiting Inflammatory Cytokines.
    Su K; Zeng P; Liang W; Luo Z; Wang Y; Lv X; Han Q; Yan M; Chen C
    Mediators Inflamm; 2017; 2017():3701385. PubMed ID: 28270699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Effects of Long Term FTY720 Treatment on Endothelial versus Smooth Muscle Cell Signaling to S1P in Rat Mesenteric Arteries.
    Hamidi Shishavan M; Bidadkosh A; Yazdani S; Lambooy S; van den Born J; Buikema H; Henning RH; Deelman LE
    PLoS One; 2016; 11(9):e0162029. PubMed ID: 27583547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockage of Central Sphingosine-1-phosphate Receptor does not Abolish the Protective Effect of FTY720 in Early Brain Injury after Experimental Subarachnoid Hemorrhage.
    Hasegawa Y; Uekawa K; Kawano T; Suzuki H; Kim-Mitsuyama S
    Curr Drug Deliv; 2017 Sep; 14(6):861-866. PubMed ID: 27605019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fingolimod suppressed the chronic unpredictable mild stress-induced depressive-like behaviors via affecting microglial and NLRP3 inflammasome activation.
    Guo Y; Gan X; Zhou H; Zhou H; Pu S; Long X; Ren C; Feng T; Tang H
    Life Sci; 2020 Dec; 263():118582. PubMed ID: 33058911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GluN2B-containing NMDA receptors are upregulated in plasma membranes by the sphingosine-1-phosphate analog FTY720P.
    Attiori Essis S; Laurier-Laurin ME; Pépin É; Cyr M; Massicotte G
    Brain Res; 2015 Oct; 1624():349-358. PubMed ID: 26260438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (S)-FTY720-vinylphosphonate, an analogue of the immunosuppressive agent FTY720, is a pan-antagonist of sphingosine 1-phosphate GPCR signaling and inhibits autotaxin activity.
    Valentine WJ; Kiss GN; Liu J; E S; Gotoh M; Murakami-Murofushi K; Pham TC; Baker DL; Parrill AL; Lu X; Sun C; Bittman R; Pyne NJ; Tigyi G
    Cell Signal; 2010 Oct; 22(10):1543-53. PubMed ID: 20566326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sphingosine 1-phosphate analogue, FTY720, modulates the lipidomic signature of the mouse hippocampus.
    Magalhães DM; Stewart NA; Mampay M; Rolle SO; Hall CM; Moeendarbary E; Flint MS; Sebastião AM; Valente CA; Dymond MK; Sheridan GK
    J Neurochem; 2024 Jun; 168(6):1113-1142. PubMed ID: 38339785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.